Pharmacologic inhibition of NOS using l-NMMA also decreased pneumonitis and increased survival following intranasal infection of CBA/J mice with HSV-1, despite a 17-fold increase in viral titers in the lung at day 3 after inoculation (58). The gene discussed is NOS1; the disease is pneumonitis.